Gamma Linolenic Acid Exerts Anti-Inflammatory and Anti-Fibrotic Effects in Diabetic Nephropathy

키워드

참고문헌 (36)

1. Wolf G, "Molecular mechanisms of diabetic renal hypertrophy", Kidney Int, 56, pp.393~405 (1999)
2. Chen S, "Diabetic nephropathy and transforming growth factor-beta: transforming our view of glomerulosclerosis and fibrosis build-up", Semin Nephrol, 23, pp.532~543 (2003)
3. Solini A, "Purinergic modulation of mesangial extracellular matrix production: role in diabetic and other glomerular diseases", Kidney Int, 67, pp.875~885 (2005)
4. Navarro-González JF, "The role of inflammatory cytokines in diabetic nephropathy", J Am Soc Nephrol, 19, pp.433~442 (2008)
5. Furuta T, "The role of macrophages in diabetic glomerulosclerosis", Am J Kidney Dis, 21, pp.480~485 (1993)
6. Young BA, "Cellular events in the evolution of experimental diabetic nephropathy", Kidney Int, 47, pp.935~944 (1995)
7. Banba N, "Possible relationship of monocyte chemoattractant protein-1 with diabetic nephropathy", Kidney Int, 58, pp.684~690 (2000)
8. Sugimoto H, "Increased expression of intercellular adhesion molecule-1 (ICAM-1) in diabetic rat glomeruli: glomerular hyperfiltration is a potential mechanism of ICAM-1 upregulation", Diabetes, 46, pp.2075~2081 (1997)
9. Utimura R, "Mycophenolate mofetil prevents the development of glomerular injury in experimental diabetes", Kidney Int, 63, pp.209~216 (2003)
10. Nasrallah R, "Chronic COX inhibition reduces diabetes-induced hyperfiltration, proteinuria, and renal pathological markers in 36-week B6-Ins2 (Akita) mice", Am J Nephrol, 30, pp.346~353 (2009)
11. Benatti P, "Polyunsaturated fatty acids: biochemical, nutritional and epigenetic properties", J Am Coll Nutr, 23, pp.281~302 (2004)
12. Buist PH, "Fatty acid desaturases: selecting the dehydrogenation channel", Nat Prod Rep, 21, pp.249~262 (2004)
13. Fan YY, "Importance of dietary gamma-linolenic acid in human health and nutrition", J Nutr, 128, pp.1411~1414 (1998)
14. Ingram AJ, "Dietary alteration of dihomogamma-linolenic acid", arachidonic acid ratio in a rat 5, J Am Soc Nephrol, pp.1996, 7[DOI]
15. Zurier RB, "gamma-Linolenic acid treatment of rheumatoid arthritis. A randomized, placebo-controlled trial", Arthritis Rheum, 39, pp.1808~1817 (1996)
16. Keen H, "Treatment of diabetic neuropathy with gamma-linolenic acid. The gamma-Linolenic Acid Multicenter Trial Group", Diabetes Care, 16, pp.8~15 (1993)
17. Li JJ, "Colchicine attenuates inflammatory cell infiltration and extracellular matrix accumulation in diabetic nephropathy", Am J Physiol Renal Physiol, 297, pp.200~209 (2009)
18. Huang GT, "Infection of human intestinal epithelial cells with invasive bacteria upregulates apical intercellular adhesion molecule-1 (ICAM)-1) expression and neutrophil adhesion", J Clin Invest, 98, pp.572~583 (1996)
19. Rovin BH, "Cytokine-induced production of monocyte chemoattractant protein-1 by cultured human mesangial cells", J Immunol, 148, pp.2148~2153 (1992)
20. Chiarelli F, "Circulating monocyte chemoattractant protein-1 and early development of nephropathy in type 1 diabetes", Diabetes Care, 25, pp.1829~1834 (2002)
21. Coimbra TM, "Early events leading to renal injury in obese Zucker (fatty) rats with type II diabetes", Kidney Int, 57, pp.167~182 (2000)
22. 여은실, "Tumor Necrosis Factor (TNF-α) and C-reactive Protein (CRP) are Positively Associated with the Risk of Chronic Kidney Disease in Patients with Type 2 Diabetes", Yonsei Medical Journal, 51(4), pp.519~525 (2010), 연세대학교의과대학
23. Kikuchi Y, "Mizoribine reduces renal injury and macrophage infiltration in non-insulin-dependent diabetic rats", Nephrol Dial Transplant, 20, pp.1573~1581 (2005)
24. Chow FY, "Intercellular adhesion molecule-1 deficiency is protective against nephropathy in type 2 diabetic db", db mice, 2005, pp.16, 1711~1722
25. Chow FY, "Monocyte chemoattractant protein-1-induced tissue inflammation is critical for the development of renal injury but not type 2 diabetes in obese db", db mice, 2007, pp.50, 471~480
26. Kim DK, "Translationally controlled tumour protein is associated with podocyte hypertrophy in a mouse model of type 1 diabetes", Diabetologia, 55, pp.1205~1217 (2012)
27. Nolin L, "Management of IgA nephropathy: evidence-based recommendations", Kidney Int Suppl, 70, pp.56~62 (1999)
28. Fassett RG, "Omega-3 polyunsaturated fatty acids in the treatment of kidney disease", Am J Kidney Dis, 56, pp.728~742 (2010)
29. Das UN, "Essential fatty acid metabolism in patients with essential hypertension, diabetes mellitus and coronary heart disease", Prostaglandins Leukot Essent Fatty Acids, 52, pp.387~391 (1995)
30. Hounsom L, "A lipoic acid-gamma linolenic acid conjugate is effective against multiple indices of experimental diabetic neuropathy", Diabetologia, 41, pp.839~843 (1998)
31. Forman BM, "Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta", Proc Natl Acad Sci U S A, 94, pp.4312~4317 (1997)
32. Pham H, "Activation of peroxisome proliferator-activated receptor (PPAR)-gamma by 15S-hydroxyeicosatrienoic acid parallels growth suppression of androgen-dependent prostatic adenocarcinoma cells", Cancer Lett, 189, pp.17~25 (2003)
33. Daynes RA, "Emerging roles of PPARs in inflammation and immunity", Nat Rev Immunol, 2, pp.748~759 (2002)
34. Zhang Y, "PPAR-gamma agonists and diabetic nephropathy", Curr Diab Rep, 5, pp.470~475 (2005)
35. Watanabe M, "Amelioration of diabetic nephropathy in OLETF rats by prostaglandin I(2) analog, beraprost sodium", Am J Nephrol, 30, pp.1~11 (2009)
36. Takata S, "Remodeling of neutrophil phospholipids with 15(S)-hydroxyeicosatetraenoic acid inhibits leukotriene B4-induced neutrophil migration across endothelium", J Clin Invest, 93, pp.499~508 (1994)

관련 논문AI추천